|Last Price$118.62||Day Change (%)-1.11%|
|Open Price$120.00||Day Change ($)-1.33|
|Day Range118.19–120.16||52-Week Range81.46–121.33|
As of Fri 09/12/2014 03:38 PM EST | USD
UPDATE: This one stock sector can withstand all the 'bubble' talk
Mark Farrah Associates Assesses 1st Quarter 2014 Performance of Top Health Plans
Over 750 Healthcare Organizations to Participate in CyberRX 2.0
IBM Watson Ushers in a New Era of Data-Driven Discoveries
SM Energy Announces Appointment of Director
In this second excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins detail how companies leverage cost advantage and switching costs to their benefit.
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
Berkshire's portfolio can give some guidance to weary investors.
Health-care exchanges provide the biggest uncertainty going into 2014.